These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3455809)
1. Antitumour imidazotetrazines-X. Effect of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4-(3H)-one (CCRG 81045; M & B 39831; NSC 362856) on DNA methylation during induction of haemoglobin synthesis in human leukaemia cell line K562. Tisdale MJ Biochem Pharmacol; 1986 Jan; 35(2):311-6. PubMed ID: 3455809 [TBL] [Abstract][Full Text] [Related]
2. Antitumour imidazotetrazines--XI: Effect of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one [CCRG 81045; M and B 39831 NSC 362856] on poly(ADP-ribose) metabolism. Tisdale MJ Br J Cancer; 1985 Nov; 52(5):789-92. PubMed ID: 3864485 [No Abstract] [Full Text] [Related]
3. Induction of haemoglobin synthesis in the human leukaemia cell line K562 by monomethyltriazenes and imidazotetrazinones. Tisdale MJ Biochem Pharmacol; 1985 Jun; 34(12):2077-82. PubMed ID: 3859296 [TBL] [Abstract][Full Text] [Related]
4. Glyoxalase activity during differentiation of human leukaemia cells in vitro. Hooper NI; Tisdale MJ; Thornalley PJ Leuk Res; 1987; 11(12):1141-8. PubMed ID: 3480403 [TBL] [Abstract][Full Text] [Related]
5. Antitumour imidazotetrazines--XVIII. Modification of the level of 5-methylcytosine in DNA by 3-substituted imidazotetrazinones. Tisdale MJ Biochem Pharmacol; 1989 Apr; 38(7):1097-101. PubMed ID: 2706009 [TBL] [Abstract][Full Text] [Related]
8. Antitumour imidazotetrazines--IV. An investigation into the mechanism of antitumour activity of a novel and potent antitumour agent, mitozolomide (CCRG 81010, M & B 39565; NSC 353451). Horgan CM; Tisdale MJ Biochem Pharmacol; 1984 Jul; 33(14):2185-92. PubMed ID: 6147140 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Stevens MF; Hickman JA; Langdon SP; Chubb D; Vickers L; Stone R; Baig G; Goddard C; Gibson NW; Slack JA Cancer Res; 1987 Nov; 47(22):5846-52. PubMed ID: 3664486 [TBL] [Abstract][Full Text] [Related]
10. Temozolomide induced differentiation of K562 leukemia cells is not mediated by gene hypomethylation. Zucchetti M; Catapano CV; Filippeschi S; Erba E; D'Incalci M Biochem Pharmacol; 1989 Jul; 38(13):2069-75. PubMed ID: 2660797 [TBL] [Abstract][Full Text] [Related]
12. DNA methylation in friend erythroleukemia cells: the effects of chemically induced differentiation and of treatment with inhibitors of DNA methylation. Christman JK Curr Top Microbiol Immunol; 1984; 108():49-78. PubMed ID: 6201322 [No Abstract] [Full Text] [Related]
13. Human leukemia K-562 cells: induction of erythroid differentiation by 5-azacytidine. Gambari R; del Senno L; Barbieri R; Viola L; Tripodi M; Raschellà G; Fantoni A Cell Differ; 1984 Jun; 14(2):87-97. PubMed ID: 6205767 [TBL] [Abstract][Full Text] [Related]
14. Antitumour imidazotetrazines--XXIV. Growth suppression by DNA from cells treated with imidazotetrazinones. Hepburn PA; Tisdale MJ Biochem Pharmacol; 1991 Feb; 41(3):339-43. PubMed ID: 1994893 [TBL] [Abstract][Full Text] [Related]
15. Antitumor imidazotetrazines--XV. Role of guanine O6 alkylation in the mechanism of cytotoxicity of imidazotetrazinones. Tisdale MJ Biochem Pharmacol; 1987 Feb; 36(4):457-62. PubMed ID: 3470008 [TBL] [Abstract][Full Text] [Related]
16. Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II). Marazzi L; Parodi MT; Di Martino D; Ferrari S; Tonini GP Anticancer Res; 1991; 11(2):947-52. PubMed ID: 2064352 [TBL] [Abstract][Full Text] [Related]
17. Antitumor imidazotetrazines. 40. Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studies. Brown GD; Luthra SK; Brock CS; Stevens MF; Price PM; Brady F J Med Chem; 2002 Dec; 45(25):5448-57. PubMed ID: 12459013 [TBL] [Abstract][Full Text] [Related]
18. Antitumour imidazotetrazines--VIII. Uptake and decomposition of a novel antitumour agent mitozolomide (CCRG 81010; M and B 39565; NSC 353451) in TLX5 mouse lymphoma in vitro. Horgan CM; Tisdale MJ Biochem Pharmacol; 1985 Jan; 34(2):217-21. PubMed ID: 3966923 [TBL] [Abstract][Full Text] [Related]
19. Naturally occurring methylation inhibitor: DNA hypomethylation and hemoglobin synthesis in human K562 cells. Lyon SB; Buonocore L; Miller M Mol Cell Biol; 1987 May; 7(5):1759-63. PubMed ID: 3474516 [TBL] [Abstract][Full Text] [Related]
20. DNA hypomethylation and differentiation in Friend leukemia cell variants. Palitti F; Carotti D; Busiello V; Bendicenti A; Strom R; Di Girolamo M Biochim Biophys Acta; 1993 Oct; 1216(1):50-4. PubMed ID: 8218415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]